IMAT - ultrafast tomography for coronary artery disease Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mantle7 who wrote (2554)	6/20/1998 1:49:00 PM
From: stock bull	Read Replies (3) of 3725

Mantle, why do you think IMAT entered into another marketing agreement after just getting out from under the Siemen's agreement? I thought that IMAT was going to go it alone. I starting to believe that IMAT's management doesn't really know how to run the company. It's one problem after another. I have concluded that IMAT should be treated as a trading vehicle, not as a long term investment. The stock sure seems to trade between 3.50 and 2.50. The only thing that moves the stock are the periodic news releases. Stock Bull

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next